In:
Current Directions in Biomedical Engineering, Walter de Gruyter GmbH, Vol. 5, No. 1 ( 2019-09-01), p. 117-118
Kurzfassung:
The consortium RESPONSE is a cooperation between partners from science and industry within the BMBF-Program “Twenty20 - Partnership for Innovation”, 2014-2021. RESPONSE gives its partners opportunities to put medical device innovations into practice more efficiently. In order to accelerate innovation processes, joint efforts are being made along the entire translation chain. RESPONSE is focusing on the development of novel concepts of implantable medical devices for cardiovascular, ophthalmologic and ENT application. Platform technology approaches are being used to extend the range of device applications. See also: www.response.uni-rostock.de
Materialart:
Online-Ressource
ISSN:
2364-5504
DOI:
10.1515/cdbme-2019-0030
Sprache:
Englisch
Verlag:
Walter de Gruyter GmbH
Publikationsdatum:
2019
ZDB Id:
2835398-5
